It’s hard to believe that 12 years have passed since the Life Raft Group officially became a non-profit organization. We have accomplished so much during that time, and look forward to accomplishing more, keeping in [...]
Two recent articles highlight the need to focus attention on cancers that have previously been less widely acknowledged by both funding and attention by the general public. The first article from the Genetic Engineering [...]
In preparation for July 13th's GIST Awareness Day we have invited top advocates to share their best strategies on how to campaign for change and raise awareness about GIST.
In a recent article from Biomed Central, the importance of epigenomics and the Human Genome Project and more recent cancer- focused initiatives are discussed. A new paradigm being explored is the idea of C2c (cancer [...]
At the recent American Society of American Oncology Meeting (ASCO), Dr. George Demetri, Director of the Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, presented results from a collaborative trial that indicates in [...]
A recent article from Cancer Research UK discusses immunotherapy, and the attention its role in the future of cancer treatment may play. In response to the interest in immunotherapy at the 50th Annual Meeting of [...]
George Demetri, MD, Senior Vice President for Experimental Therapeutics at Dana-Farber Cancer Institute, discusses the lasting benefit of targeted therapy that included Gleevec in advanced GIST at the recent 50th Annual Meeting of the American Society [...]
New research on innovative immunotherapy treatments was presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). Immunotherapy is used in fighting cancer by activating and amplifying the patient’s immune response [...]
Today is White Out Cancer Day. In order to honor Cancer Immunotherapy Month, The Cancer Research Institute is encouraging everyone to wear white today. Immunotherapy is a promising field in cancer research and treatment that [...]
Immunotherapy treatments garnered a great deal of attention at the Annual Meeting of the American Society of Clinical Oncology (ASCO). This article from the New York Times discusses this form of treatment and its [...]
